HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.
Símbolo de cotizaciónBEATW
Nombre de la empresaHeartbeam Inc
Fecha de salida a bolsaOct 14, 2021
Director ejecutivoMr. Robert P. (Rob) Eno
Número de empleados- -
Tipo de seguridadCompany Warrant
Fin del año fiscal- -
Dirección2118 Walsh Ave., Suite 210
CiudadSANTA CLARA
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal95050
Teléfono14088994443
Sitio Webhttps://www.heartbeam.com/
Símbolo de cotizaciónBEATW
Fecha de salida a bolsaOct 14, 2021
Director ejecutivoMr. Robert P. (Rob) Eno
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos